(Q51494757)

5 April 2018

title

Intravenous administration of bone marrow mesenchymal stromal cells is safe for the lung in a chronic myocardial infarction model. (English)

1 reference

5 April 2018

main subject

myocardial infarction

1 reference

Wei Wang

1

1 reference

5 April 2018

Qin Jiang

2

1 reference

5 April 2018

Hao Zhang

3

1 reference

5 April 2018

Peifeng Jin

4

1 reference

5 April 2018

Xin Yuan

5

1 reference

5 April 2018

Yingjie Wei

6

1 reference

5 April 2018

Shengshou Hu

7

1 reference

5 April 2018

publication date

1 March 2011

1 reference

5 April 2018

published in

Regenerative Medicine

1 reference

5 April 2018

volume

6

1 reference

5 April 2018

issue

2

1 reference

5 April 2018

page(s)

179-190

1 reference

5 April 2018

Mesenchymal stem cells for vascular regeneration

cites work

1 reference

https://api.crossref.org/works/10.2217%2FRME.10.104

Intramyocardial bone marrow cell injection for chronic myocardial ischemia: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FRME.10.104

Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FRME.10.104

A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FRME.10.104

Intravenously injected mesenchymal stem cells home to viable myocardium after coronary occlusion and preserve systolic function without altering infarct size

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FRME.10.104

Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FRME.10.104

Cellular cardiomyoplasty and cardiac tissue engineering for myocardial therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FRME.10.104

Increasing donor age adversely impacts beneficial effects of bone marrow but not smooth muscle myocardial cell therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FRME.10.104

Cartilage-derived stromal cells: is it a novel cell resource for cell therapy to regenerate infarcted myocardium?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FRME.10.104

Aging adversely impacts biological properties of human bone marrow-derived mesenchymal stem cells: implications for tissue engineering heart valve construction.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FRME.10.104

Transplantation of microencapsulated genetically modified xenogeneic cells augments angiogenesis and improves heart function

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FRME.10.104

L-Arginine prevents air embolism-induced acute lung injury in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FRME.10.104

Baicalin attenuates air embolism-induced acute lung injury in rat isolated lungs

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FRME.10.104

Role of cardiopulmonary bypass and arrested heart status in the early cell distribution after intracoronary infusion of bone marrow stromal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FRME.10.104

Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FRME.10.104

Cell-based therapy of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FRME.10.104

Catheter-based delivery of cells to the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FRME.10.104

Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FRME.10.104

Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FRME.10.104

Tracking cardiac engraftment and distribution of implanted bone marrow cells: Comparing intra-aortic, intravenous, and intramyocardial delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FRME.10.104

Cellular cardiomyoplasty: routes of cell delivery and retention

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FRME.10.104

Fate of culture-expanded mesenchymal stem cells in the microvasculature: in vivo observations of cell kinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FRME.10.104

Pulmonary applications and toxicity of engineered nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FRME.10.104

Stem cells for lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FRME.10.104

TSG-6: a pluripotent inflammatory mediator?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FRME.10.104

Anti-inflammatory protein TSG-6 reduces inflammatory damage to the cornea following chemical and mechanical injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FRME.10.104

Differences in inflammation, MMP activation and collagen damage account for gender difference in murine cardiac rupture following myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FRME.10.104

Metalloproteinase inhibitor counters high-energy phosphate depletion and AMP deaminase activity enhancing ventricular diastolic compliance in subacute heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FRME.10.104

Intravenous mesenchymal stem cell therapy for traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FRME.10.104

21 January 2018

Identifiers

DOI

10.2217/RME.10.104

1 reference

5 April 2018

PubMed ID

21391852

1 reference

5 April 2018